Literature DB >> 9926164

The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards.

A N McLean1, P A Semple, D H Franklin, G Petrie, E A Millar, J G Douglas.   

Abstract

Fibre-optic bronchoscopy is widely used to diagnose bronchial carcinoma. There is considerable variation in techniques for patient sedation, methods of obtaining samples and histopathological yield. We wished to examine variations in practice in different centres throughout Scotland and derive realistic audit standards for best clinical practice from these results. Diagnostic bronchoscopies from five centres were included. Patient details, grade of individual performing the test, endobronchial abnormalities, specimens taken and the histocytological yield were recorded. A patient satisfaction questionnaire was completed. One thousand eight hundred and two bronchoscopies were performed to look for bronchial carcinoma. Sedation and anaesthesia techniques varied considerably between centres. There were marked differences in patient satisfaction between centres. Nearly twice as many females as males would prefer not to have bronchoscopy repeated. Six hundred and fifty-eight carcinomas were confirmed by histocytology. Yield was unaffected by the grade of doctor performing bronchoscopy. Improving yield may be achieved by increasing the number of sampling techniques employed and changing the order in which specimens are taken (biopsies first and washings last). Eighty-seven percent of endoscopically visible tumours were confirmed histocytologically. There was a considerable variation in histological spectra between centres that may relate to differences in pathological interpretation rather than actual differences in case mix. Suggested audit standards are discussed. This study demonstrates the variety of techniques and also the levels of histocytological yield and patient satisfaction that can be achieved. Provisional standards of practice for this procedure have been agreed with a view to auditing performance against these. It is hoped that centres will adopt the methods that are shown to achieve the highest standards.

Entities:  

Mesh:

Year:  1998        PMID: 9926164     DOI: 10.1016/s0954-6111(98)90403-6

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  British Thoracic Society guidelines on diagnostic flexible bronchoscopy.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

Review 2.  The role of bronchoscopy in the diagnosis of airway disease.

Authors:  Tyler J Paradis; Jennifer Dixon; Brandon H Tieu
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.

Authors:  A Gregor; C S Thomson; D H Brewster; P L Stroner; J Davidson; R J Fergusson; R Milroy
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

4.  Bronchoscopy in rural areas?

Authors:  Reidar Berntsen; Erik Waage Nielsen
Journal:  Pulm Med       Date:  2012-02-06

5.  Increased microRNA-30a levels in bronchoalveolar lavage fluid as a diagnostic biomarker for lung cancer.

Authors:  Wen-Jun Zhu; Bo-Jiang Chen; Ying-Ying Zhu; Ling Sun; Yu-Chen Zhang; Huan Liu; Feng-Ming Luo
Journal:  PeerJ       Date:  2021-06-09       Impact factor: 2.984

6.  Quantitative analysis of survivin protein expression and its therapeutic depletion by an antisense oligonucleotide in human lung tumors.

Authors:  Anna L Olsen; Joanne M Davies; Louise Medley; David Breen; Denis C Talbot; Peter J McHugh
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-19       Impact factor: 10.183

7.  Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques.

Authors:  Kjetil Roth; Jon A Hardie; Alf H Andreassen; Friedemann Leh; Tomas Ml Eagan
Journal:  BMC Pulm Med       Date:  2008-01-26       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.